| Professional Rehabiliation Services | |
|
2140 Oakheart Rd, Myrtle Beach, SC 29579-1253 | |
| (843) 282-0440 | |
| (843) 353-2060 |
| Full Name | Professional Rehabiliation Services |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 2140 Oakheart Rd, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053802330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3690 (South Carolina) | Primary |
| Provider Name | Brian P Kinmartin |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1730137506 PECOS PAC ID: 6901894138 Enrollment ID: I20040507000046 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Richard A Owens |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750331005 PECOS PAC ID: 9931108099 Enrollment ID: I20061219000142 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Richard A Defalco |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1578693131 PECOS PAC ID: 0345334876 Enrollment ID: I20111025000000 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Jill F Phelan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760891881 PECOS PAC ID: 4385865161 Enrollment ID: I20141020001979 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Lisa M Obrien |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558734517 PECOS PAC ID: 6305143975 Enrollment ID: I20160324002265 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Karl Ehlers |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1982052981 PECOS PAC ID: 3779868765 Enrollment ID: I20170313001790 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Zachary Daniels |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144700444 PECOS PAC ID: 1658624549 Enrollment ID: I20181023001088 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Samantha A Crisafulli |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528548948 PECOS PAC ID: 6901150150 Enrollment ID: I20181107001238 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Brandon M Stanley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558820472 PECOS PAC ID: 4880921006 Enrollment ID: I20190812001224 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Daniel J Staples |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033771357 PECOS PAC ID: 2961733282 Enrollment ID: I20191016003754 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Taylor M Dawley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1164142386 PECOS PAC ID: 9638545387 Enrollment ID: I20221020000969 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Provider Name | Kayla Carlisle |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629782594 PECOS PAC ID: 7315310943 Enrollment ID: I20230302000675 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Professional Rehabiliation Services Po Box 2397, Pawleys Island, SC 29585-2397 Ph: (843) 235-0200 | Professional Rehabiliation Services 2140 Oakheart Rd, Myrtle Beach, SC 29579-1253 Ph: (843) 282-0440 |
News Archive
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
› Verified 7 days ago
Jason M Anders, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 201 Brightwater Dr, Myrtle Beach, SC 29579 Phone: 304-236-4131 Fax: 304-236-4131 | |
Gavin Stepansky, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4871 Socastee Blvd Unit E, Myrtle Beach, SC 29588 Phone: 843-293-5610 | |
Karyn Longo Congdon, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3515 Caduceus Dr, Ste A, Myrtle Beach, SC 29588 Phone: 843-293-7085 | |
Mr. Thomas A. Palya, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4012 Postal Way, Suite C, Myrtle Beach, SC 29579 Phone: 843-903-4940 | |
Dr. Tamala Rose Marcin, PT,DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 716 Morning Star Ct, Myrtle Beach, SC 29579 Phone: 317-430-6283 Fax: 843-236-9544 | |
Benchmark Healthcare Service Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7955 N Kings Hwy Ste 330, Myrtle Beach, SC 29572 Phone: 843-945-1815 Fax: 843-945-2343 |